Evidence map›Paper›PMID 28687497›Full record

ArticleEBioMedicine2017

The Protein Encoded by the CCDC170 Breast Cancer Gene Functions to Organize the Golgi-Microtubule Network.

Pengtao Jiang, Yueran Li, Andrey Poleshko, Valentina Medvedeva, Natalia Baulina, Yongchao Zhang, Yan Zhou, Carolyn M Slater, Trinity Pellegrin, Jason Wasserman and 5 more

Abstract read
In one paragraph

Article in EBioMedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Water channel protein AQP1 in cytoplasm is a critical factor in breast cancer local invasion.Journal of experimental & clinical cancer research : CR · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Pengtao JiangCancer Epigenetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, United States. Electronic address: Pengtao.Jiang@fccc.edu.
Yueran LiCancer Epigenetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, United States. Electronic address: liyueran1986@126.com.
Andrey PoleshkoCancer Epigenetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, United States. Electronic address: poleshko@mail.med.upenn.edu.
Valentina MedvedevaCancer Epigenetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, United States. Electronic address: Valentina.Medvedeva@fccc.edu.
Natalia BaulinaCancer Epigenetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, United States. Electronic address: tati.90@mail.ru.
Yongchao ZhangCancer Epigenetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, United States. Electronic address: zhangycqh@yahoo.com.
Yan ZhouDepartment of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, PA 19111, United States. Electronic address: Yan.Zhou@fccc.edu.
Carolyn M SlaterCancer Epigenetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, United States. Electronic address: Carolyn.Slater@fccc.edu.
Trinity PellegrinCancer Epigenetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, United States. Electronic address: Trinity.Pellegrin@fccc.edu.
Jason WassermanCancer Epigenetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, United States. Electronic address: tue48797@temple.edu.
Michael LindyCancer Epigenetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, United States. Electronic address: michaelnlindy@gmail.com.
Andrey EfimovCancer Epigenetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, United States. Electronic address: Andrey.Efimov@fccc.edu.
Mary DalyDepartment of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA 19111, United States. Electronic address: Mary.Daly@fccc.edu.
Richard A KatzCancer Epigenetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, United States. Electronic address: Richard.Katz@fccc.edu.
Xiaowei ChenCancer Epigenetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, United States. Electronic address: Xiaowei.Chen@fccc.edu.

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Michael Jackson · 1985 to 2026
$107.2M
A Novel Allele-Specific RNA-ISH for Differential Allele-specific ExpressionR21CA186853 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CHEN, XIAOWEI · 2014 to 2016
$776k
NCI NIH HHS P30 CA006927NCI NIH HHS P30 CA030199NCI NIH HHS R21 CA186853
6 · The paper itself

Abstract

Genome-Wide Association Studies (GWAS) and subsequent fine-mapping studies (>50) have implicated single nucleotide polymorphisms (SNPs) located at the CCDC170/C6ORF97-ESR1 locus (6q25.1) as being associated with the risk of breast cancer. Surprisingly, our analysis using genome-wide differential allele-specific expression (DASE), an indicator for breast cancer susceptibility, suggested that the genetic alterations of CCDC170, but not ESR1, account for GWAS-associated breast cancer risk at this locus. Breast cancer-associated CCDC170 nonsense mutations and rearrangements have also been detected, with the latter being specifically implicated in driving breast cancer. Here we report that the wild type CCDC170 protein localizes to the region of the Golgi apparatus and binds Golgi-associated microtubules (MTs), and that breast cancer-linked truncations of CCDC170 result in loss of Golgi localization. Overexpression of wild type CCDC170 triggers Golgi reorganization, and enhances Golgi-associated MT stabilization and acetyltransferase ATAT1-dependent α-tubulin acetylation. Golgi-derived MTs regulate cellular polarity and motility, and we provide evidence that dysregulation of CCDC170 affects polarized cell migration. Taken together, our findings demonstrate that CCDC170 plays an essential role in Golgi-associated MT organization and stabilization, and implicate a mechanism for how perturbations in the CCDC170 gene may contribute to the hallmark changes in cell polarity and motility seen in breast cancer.

Indexed as

AcetylationBreast NeoplasmsCarrier ProteinsCell Line, TumorCell MovementCell PolarityFemaleGenetic Predisposition to DiseaseGolgi ApparatusHumansMCF-7 CellsMicrotubulesPolymorphism, Single NucleotideProtein BindingCarrier ProteinsCCDC170 protein, humanCCDC170/C6ORF97Differential allele specific expression (DASE)Genome-wide association studies (GWAS)Golgi-associated microtubulesPolarized cell migrationTubulin acetylation

Identifiers

PMID28687497
PMCPMC5552109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.